Author

Kimiko Della Croce

Observed names: K Della Croce, K. Della Croce, K.Della Croce, Kimiko D. Croce

Institution: University of Arizona

Observed institutions: University of Arizona, University of Arizona Cancer Center

ORCID: 0000-0002-1596-3454

Observed ORCID: 0000-0002-1596-3454

OpenAlex ID: A5033512976

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors

2007 · D Mahadevan, L Cooke, et al. · Oncogene · 280

Controlling Depth of Cellular Quiescence by an Rb-E2F Network Switch

2017 · Jungeun Sarah Kwon, Nicholas J. Everetts, et al. · Cell Reports · 132

Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch

2019 · Kotaro Fujimaki, Ruoyan Li, et al. · Proceedings of the National Academy of Sciences · 130

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

2005 · Daruka Mahadevan, Catherine Spier, et al. · Molecular Cancer Therapeutics · 96

Effects of the steroid hormone, 20-hydroxyecdysone, on the growth of neurites by identified insect motoneurons in vitro

1992 · J. Prugh, K.Della Croce, et al. · Developmental Biology · 87

MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

2009 · Wenqing Qi, Larry S Cooke, et al. · BMC Cancer · 56

Exit from quiescence displays a memory of cell growth and division

2017 · Xia Wang, Kotaro Fujimaki, et al. · Nature Communications · 55

The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer

2015 · Wenjing Zhang, Xinli Tian, et al. · BMC Cancer · 36

Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer

2009 · Christopher J. Riley, Kevin P. Engelhardt, et al. · Cancer Research · 36

Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia

2006 · Daruka Mahadevan, Johanna DiMento, et al. · American Journal of Hematology · 30

Multi-wavelength quantitative polarization and phase microscope

2019 · Xiaobo Tian, Xingzhou Tu, et al. · Biomedical Optics Express · 23

Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy

2020 · Bi Liu, Yunzhu Shen, et al. · Cell Communication and Signaling · 11

AT7519, a Potent CDK Inhibitor, Is Active in Leukemia Models and Primary CLL Patient Samples.

2007 · Matthew S. Squires, Ruth E. Feltell, et al. · Blood · 3

AT7519, a Potent Multi-Targeted CDK Inhibitor, Is Active in CLL Patient Samples Independent of Stage

2008 · Vicky Lock, Laurence Cooke, et al. · Blood · 2

Gene Expression Profiling of Peripheral T-Cell Lymphoma (PTCL, NOS) and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL).

2004 · Daruka Mahadevan, Catherine Spier, et al. · Blood · 1

Works count: 15

Citation count: 978

H-index: 11

I10-index: 12